Better Health for All

No specific, quantitative evidence was found across the provided articles to score any of the KPIs for 'Better Health for All'. The articles primarily consist of company marketing material and financial reports, which describe the company's products (radiation therapy systems for cancer treatment) but do not contain data on health impact quantification, safety records, pricing accessibility, vulnerable population reach, risk transparency, R&D allocation for health improvement, health externalities, equity programs, workforce support, preventative measures, data responsibility, crisis response, mental health initiatives, healthcare education, or clinical trial ethics.

Therefore, all KPIs are omitted due to lack of explicit, quantifiable evidence that maps to the rubric's thresholds.

Fair Money & Economic Opportunity

Accuray Incorporated is a radiation oncology company that develops, manufactures, and sells treatment solutions for cancer patients.

The 'Fair Money & Economic Opportunity' value is designed to assess financial institutions and their provision of lending, insurance, or deposit services to consumers, particularly underserved populations. The provided articles detail Accuray's financial performance, corporate credit facilities, and environmental metrics. There is no evidence in the articles that Accuray offers any financial products or services to consumers, nor does it engage in activities related to financial inclusion, lending, or wealth building for individuals or communities. Consequently, no specific, concrete data points were found in the articles to score any of the KPIs under this value.

Fair Trade & Ethical Sourcing

Accuray has not reported any substantiated forced or child labor incidents in the last three years, and its Supplier Code of Conduct strictly prohibits such practices.

For conflict minerals, 86% of in-scope suppliers responded to requests for information, with 100% of those providing a template. However, only 26 suppliers provided templates incorporating responses from 100% of their supply chain, and only 2 of those identified materials down to the mine location. Accuray endeavors to require all suppliers to accept its Supplier Code of Conduct through a contractual provision in its supply agreements. For conflict minerals, 31% of tungsten, 37% of tin, 64% of tantalum, and 50% of gold smelters and refiners identified are verified 'conflict-free'.

Honest & Fair Business

Accuray has a formal Whistleblower Policy, maintaining a secure hotline and website for anonymous reporting via an independent third-party partner, EthicsPoint, and explicitly states it will not tolerate retaliation.

The policy applies to all employees, officers, directors, agents, distributors, and contractors worldwide. The company is preparing amended Form 10-K/A and 10-Q/A to correct errors in remaining performance obligations disclosure in Note 2 of its prior fiscal 2025 Form 10-K and related 10-Qs, which constitutes one restatement in the past year. Accuray's consolidated financial statements are audited by Grant Thornton LLP, and its Madison facility was inspected by the FDA in August 2017 with no observations. The company also maintains ISO 13485 certification and is authorized to affix the CE mark, with Notified Bodies regularly auditing compliance for European sales. The 2019 Proxy Statement mentions director independence, and the board includes 8 independent directors out of 9, resulting in 88.9% independent directors. Accuray has an Anti-Corruption Policy and a Code of Conduct and Ethics that applies to all employees, officers, directors, agents, distributors, and contractors, with annual acknowledgment requirements and yearly training on the Code. The company engages Assent Compliance to assist with supplier due diligence for conflict minerals, and its Supplier Code of Conduct allows Accuray and its designated third-party agents to perform audits to review supplier compliance.

Kind to Animals

No evidence was found in the provided articles regarding Accuray Incorporated's performance on any of the 'Kind to Animals' KPIs. The articles discuss the company's general corporate social responsibility

and the application of its radiation therapy systems for treating cancer in pets , but do not provide specific data on animal testing, cruelty-free certifications, ethical sourcing, animal agriculture practices, or conservation efforts.

No War, No Weapons

Accuray Incorporated's core business is radiation oncology systems for cancer treatment. The company has no reported revenue from arms or defense contracts, with government contracts primarily with the Department of Veterans Affairs and a $0 contract with the Department of Defense.

The company's lobbying activities are focused on healthcare, trade, manufacturing, and taxation, with no mention of lobbying related to arms control. There is no evidence of exposure to controversial or banned weapons. However, the company is required to disclose the existence of certain metals, including tantalum, tin, gold, and tungsten, that originate from the Democratic Republic of the Congo and adjoining countries, without providing any percentage of its supply chain certified as conflict-free.

Planet-Friendly Business

In 2021, Accuray sourced approximately 13.69% of its total electrical energy from renewable sources across its US locations.

Specifically, 853,188 kWh of renewable energy was used at the Sunnyvale, CA headquarters, representing 50% of that location's electrical energy, while no renewable energy was used at the Madison, WI location. The company operates an e-waste management program in India, complying with the Indian E-Waste (Management) Rules 2016, and partners with a government-authorized recycler for the collection and recycling of its medical equipment e-waste. Accuray remanufactures and recertifies over 100 types of equipment and static materials for reuse and sorts and recycles process waste including precious metals, electronics, wood, and cardboard. The company works with some suppliers that have ISO 14001 or EMAS environmental management systems. In 2021, total water use in the US was 2,539,778 gallons, with no water recycled or reused. Hazardous waste disposed of in 2021 amounted to 20 pounds. No specific regulatory actions, violations, fines, or compliance issues were mentioned.